2013 annual financial data
Galectin Therapeutics 2013 Operating margin
Galectin Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -12,104,000 USD and net income was -12,088,000 USD.
Operating cash flow was -7,484,000 USD.
Get free Galectin Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,104,000 USD
- Net income
- -12,088,000 USD
- Operating cash flow
- -7,484,000 USD